ProfileGDS4095 / 222613_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 79% 80% 79% 79% 80% 80% 79% 80% 80% 79% 80% 80% 80% 80% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep18.5216779
GSM709769LY2 SRC1-siRNA tamoxifen treated rep38.7226980
GSM709765LY2 SRC1-siRNA untreated rep38.5195179
GSM709771LY2 SRC1-siRNA untreated rep18.6494679
GSM709772LY2 SRC1-siRNA untreated rep28.6928980
GSM709775LY2 SRC1-siRNA untreated rep48.7475180
GSM709764LY2 control-siRNA tamoxifen treated rep28.6245979
GSM709766LY2 control-siRNA tamoxifen treated rep38.7695480
GSM709768LY2 control-siRNA tamoxifen treated rep18.7447780
GSM709777LY2 control-siRNA tamoxifen treated rep48.6993979
GSM709770LY2 control-siRNA untreated rep38.7129180
GSM709773LY2 control-siRNA untreated rep18.787180
GSM709774LY2 control-siRNA untreated rep28.8078680
GSM709776LY2 control-siRNA untreated rep48.6993280